GENPHARMATrading & Distributors
Genpharmasec Ltd — Cash Flow Statement
₹0.78
-7.69%
Genpharmasec Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -2.71 Cr | -2.96 Cr | -3.08 Cr | -2.42 Cr | — |
| Repayment Of Debt | -0.06 Cr | -5.66 Cr | 0.00 | — | — |
| Issuance Of Debt | 0.00 | 5.48 Cr | 3.04 Cr | 0.00 | — |
| Issuance Of Capital Stock | 0.00 | 48.51 Cr | 0.00 | 0.00 | — |
| Capital Expenditure | -5.71 Cr | -0.02 Cr | -0.02 Cr | -0.08 Cr | — |
| End Cash Position | 5.27 Cr | 18.83 Cr | 1.99 Cr | 1.61 Cr | — |
| Beginning Cash Position | 18.83 Cr | 1.99 Cr | 1.61 Cr | 3.53 Cr | — |
| Changes In Cash | -13.56 Cr | 16.84 Cr | 0.39 Cr | -1.93 Cr | — |
| Financing Cash Flow | -1.25 Cr | 47.85 Cr | 3.08 Cr | 0.00 | — |
| Interest Paid Cff | -0.63 Cr | -0.37 Cr | — | — | — |
| Net Common Stock Issuance | 0.00 | 48.51 Cr | 0.00 | 0.00 | — |
| Common Stock Issuance | 0.00 | 48.51 Cr | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | -0.06 Cr | -0.18 Cr | 3.04 Cr | 0.00 | — |
| Net Long Term Debt Issuance | -0.06 Cr | -0.18 Cr | 3.04 Cr | 0.00 | — |
| Long Term Debt Payments | -0.06 Cr | -5.66 Cr | 0.00 | — | — |
| Long Term Debt Issuance | 0.00 | 5.48 Cr | 3.04 Cr | 0.00 | — |
| Investing Cash Flow | -15.31 Cr | -28.06 Cr | 0.36 Cr | 0.42 Cr | — |
| Interest Received Cfi | 2.28 Cr | 0.47 Cr | 0.02 Cr | 0.07 Cr | — |
| Net Investment Purchase And Sale | 0.00 | -17.64 Cr | 0.33 Cr | 0.27 Cr | — |
| Purchase Of Investment | 0.00 | -17.64 Cr | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | -5.71 Cr | -0.02 Cr | -0.02 Cr | -0.08 Cr | — |
| Purchase Of PPE | -5.71 Cr | -0.02 Cr | -0.02 Cr | -0.08 Cr | — |
| Operating Cash Flow | 3.00 Cr | -2.95 Cr | -3.06 Cr | -2.34 Cr | — |
| Taxes Refund Paid | -0.07 Cr | -0.04 Cr | 0.26 Cr | -0.03 Cr | — |
| Change In Working Capital | 2.23 Cr | -3.54 Cr | -3.77 Cr | -1.83 Cr | — |
| Change In Other Current Liabilities | 0.17 Cr | 0.23 Cr | 0.03 Cr | 0.02 Cr | — |
| Change In Other Current Assets | 0.42 Cr | -2.22 Cr | 0.10 Cr | 0.18 Cr | — |
| Change In Payable | 5.88 Cr | 1.01 Cr | -4.85 Cr | -0.89 Cr | — |
| Change In Inventory | 0.64 Cr | 0.83 Cr | 0.21 Cr | -2.21 Cr | — |
| Change In Receivables | -4.89 Cr | -3.39 Cr | 0.74 Cr | 1.08 Cr | — |
| Other Non Cash Items | -2.25 Cr | -0.08 Cr | 0.07 Cr | -0.07 Cr | — |
| Provisionand Write Offof Assets | 0.39 Cr | 78000.00 | 0.10 Cr | — | — |
| Depreciation And Amortization | 0.81 Cr | 0.04 Cr | 0.02 Cr | 0.01 Cr | — |
| Depreciation | 0.81 Cr | 0.04 Cr | 0.02 Cr | 0.01 Cr | — |
| Pension And Employee Benefit Expense | 0.01 Cr | — | — | — | — |
| Net Income From Continuing Operations | 1.88 Cr | 0.25 Cr | 0.28 Cr | -0.44 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 0.43 Cr | 1000.00 | -1000.00 | — |
| Net Other Investing Changes | — | -1.55 Cr | 1000.00 | -1000.00 | — |
| Sale Of Investment | — | 0.00 | 0.33 Cr | 0.27 Cr | 6.74 Cr |
| Sale Of PPE | — | 0.02 Cr | 0.00 | 17000.00 | 0.00 |
| Gain Loss On Investment Securities | — | -0.73 Cr | — | 89000.00 | — |
| Net Other Financing Charges | — | — | 0.04 Cr | — | — |
| Dividends Received Cfi | — | — | 0.00 | 3000.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Genpharmasec Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.